Tissue Procurement and Natural History Study of Neuroendocrine Neoplasms (NENs) Including Adrenocortical Carcinoma (ACC)
RecruitingOBSERVATIONAL
Enrollment
300
Participants
Timeline
Start Date
April 25, 2022
Primary Completion Date
December 31, 2032
Study Completion Date
December 31, 2032
Conditions
Neuroendocrine TumorsCarcinoma, Neuroendocrine
Trial Locations (1)
20892
RECRUITING
National Institutes of Health Clinical Center, Bethesda
All Listed Sponsors
lead
National Cancer Institute (NCI)
NIH
NCT05237934 - Tissue Procurement and Natural History Study of Neuroendocrine Neoplasms (NENs) Including Adrenocortical Carcinoma (ACC) | Biotech Hunter | Biotech Hunter